|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the School of Biomedical & Molecular Sciences, University of Surrey, Guildford, Surrey, United Kingdom (MDG, IGD, LMM, DJM, and BAG); the Nutritional Sciences Research Division, King's College London, London, United Kingdom (TABS, FL, and SS); the Centre for the Genetics of Cardiovascular Disease, Royal Free and University College London Medical School, London, United Kingdom (JAC); the Medical Research Council Cardiovascular Research Group, Wolfson Institute, Barts and The London Queen Mary's School Medicine and Dentistry, London, United Kingdom (GLM)
Background: Insulin resistance is associated with elevated plasma triacylglycerol, low HDL concentrations, elevated postprandial lipemia, and a predominance of small, dense LDLs (sdLDLs). It has been hypothesized that the dietary ratio of n6 to n3 (n6:n3) polyunsaturated fatty acids (PUFAs) may have favorable effects on these risk factors by increasing insulin sensitivity.
Objective: The objective was to measure changes in insulin sensitivity, lipoprotein size, and postprandial lipemia after a 6-mo alteration in n6:n3.
Design: In a randomized, parallel design in 258 subjects aged 4570 y, we compared 4 diets providing 6% of energy as PUFAs with an n6:n3 between 5:1 and 3:1 with a control diet that had an n6:n3 of 10:1. The diets were enriched in
-linolenic acid, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), or both. Insulin sensitivity was assessed with the homeostatic model assessment of insulin resistance and the revised quantitative insulin sensitivity test.
Results: Dietary intervention did not influence insulin sensitivity or postprandial lipase activities. Fasting and postprandial triacylglycerol concentrations were lower, and the proportion of sdLDLs decreased (by 12.7%; 95% CI: 22.9%, 2.4%), with an n6:n3 of
3:1, which was achieved by the addition of long-chain n3 PUFAs (EPA and DHA).
Conclusions: Decreasing the n6:n3 does not influence insulin sensitivity or lipase activities in older subjects. The reduction in plasma triacylglycerol after an increased intake of n3 long-chain PUFAs results in favorable changes in LDL size.
Key Words: Blood lipids n3 fatty acids n6 fatty acids insulin sensitivity lipoprotein lipase LDL HDL long-chain polyunsaturated fatty acids
This article has been cited by other articles:
![]() |
M. V. Potenza and J. I. Mechanick The Metabolic Syndrome: Definition, Global Impact, and Pathophysiology Nutr Clin Pract, October 1, 2009; 24(5): 560 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Daniel, M. L. McCullough, R. C. Patel, E. J. Jacobs, W. D. Flanders, M. J. Thun, and E. E. Calle Dietary Intake of {omega}-6 and {omega}-3 Fatty Acids and Risk of Colorectal Cancer in a Prospective Cohort of U.S. Men and Women Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 516 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
B M Yashodhara, S Umakanth, J M Pappachan, S K Bhat, R Kamath, and B H Choo Omega-3 fatty acids: a comprehensive review of their role in health and disease Postgrad. Med. J., February 1, 2009; 85(1000): 84 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shen, D. K. Arnett, J. M. Peacock, L. D. Parnell, A. Kraja, J. E. Hixson, M. Y. Tsai, C.-Q. Lai, E. K. Kabagambe, R. J. Straka, et al. Interleukin1{beta} Genetic Polymorphisms Interact with Polyunsaturated Fatty Acids to Modulate Risk of the Metabolic Syndrome J. Nutr., August 1, 2007; 137(8): 1846 - 1851. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |